Respiratory depression from alkalosis and opioid interaction in man.
D000328:Adult; D000472:Alkalosis, Respiratory / Q000503:physiopathology*; D000700:Analgesics / Q000009:adverse effects*; D000771:Anesthesia, Intravenous; D001639:Bicarbonates / Q000008:administration & dosage / Q000494:pharmacology; D001769:Blood; D002245:Carbon Dioxide / Q000097:blood / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004357:Drug Synergism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006935:Hypercapnia; D007263:Infusions, Parenteral; D008297:Male; D009019:Morphinans / Q000009:adverse effects* / Q000378:metabolism; D009270:Naloxone / Q000494:pharmacology; D010111:Oxymorphone / Q000008:administration & dosage / Q000009:adverse effects; D010919:Placebos; D012119:Respiration / Q000187:drug effects*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000494:pharmacology; D013147:Spirometry
D000700:Analgesics; D001639:Bicarbonates; D009019:Morphinans; D010919:Placebos; D002245:Carbon Dioxide; D009270:Naloxone; D012965:Sodium Chloride; D010111:Oxymorphone